Literature DB >> 27612657

Age-related alterations in immune responses to West Nile virus infection.

R R Montgomery1.   

Abstract

West Nile virus (WNV) is the most important causative agent of viral encephalitis worldwide and an important public health concern in the United States due to its high prevalence, severe disease, and the absence of effective treatments. Infection with WNV is mainly asymptomatic, but some individuals develop severe, possibly fatal, neurological disease. Individual host factors play a role in susceptibility to WNV infection, including genetic polymorphisms in key anti-viral immune genes, but age is the most well-defined risk factor for susceptibility to severe disease. Ageing is associated with distinct changes in immune cells and a decline in immune function leading to increased susceptibility to infection and reduced responses to vaccination. WNV is detected by pathogen recognition receptors including Toll-like receptors (TLRs), which show reduced expression and function in ageing. Neutrophils, monocyte/macrophages and dendritic cells, which first recognize and respond to infection, show age-related impairment of many functions relevant to anti-viral responses. Natural killer cells control many viral infections and show age-related changes in phenotype and functional responses. A role for the regulatory receptors Mertk and Axl in blood-brain barrier permeability and in facilitating viral uptake through phospholipid binding may be relevant for susceptibility to WNV, and age-related up-regulation of Axl has been noted previously in human dendritic cells. Understanding the specific immune parameters and mechanisms that influence susceptibility to symptomatic WNV may lead to a better understanding of increased susceptibility in elderly individuals and identify potential avenues for therapeutic approaches: an especially relevant goal, as the world's populating is ageing.
© 2016 British Society for Immunology.

Entities:  

Keywords:  aging; flavivirus; immunosenescence; interferon; macrophage

Mesh:

Substances:

Year:  2016        PMID: 27612657      PMCID: PMC5167051          DOI: 10.1111/cei.12863

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  121 in total

1.  Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier.

Authors:  Helen M Lazear; Brian P Daniels; Amelia K Pinto; Albert C Huang; Sarah C Vick; Sean E Doyle; Michael Gale; Robyn S Klein; Michael S Diamond
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

Review 2.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

3.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 4.  Paradoxical changes in innate immunity in aging: recent progress and new directions.

Authors:  Ruth R Montgomery; Albert C Shaw
Journal:  J Leukoc Biol       Date:  2015-07-17       Impact factor: 4.962

5.  Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.

Authors:  Virginia Castiglia; Alessandra Piersigilli; Florian Ebner; Marton Janos; Oliver Goldmann; Ursula Damböck; Andrea Kröger; Sigfried Weiss; Sylvia Knapp; Amanda M Jamieson; Carsten Kirschning; Ulrich Kalinke; Birgit Strobl; Mathias Müller; Dagmar Stoiber; Stefan Lienenklaus; Pavel Kovarik
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

6.  Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly.

Authors:  Kok-Fai Kong; Karine Delroux; Xiaomei Wang; Feng Qian; Alvaro Arjona; Stephen E Malawista; Erol Fikrig; Ruth R Montgomery
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

7.  The Interferon-Stimulated Gene Ifitm3 Restricts West Nile Virus Infection and Pathogenesis.

Authors:  Matthew J Gorman; Subhajit Poddar; Michael Farzan; Michael S Diamond
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

8.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus.

Authors:  Fengwei Bai; Kok-Fai Kong; Jianfeng Dai; Feng Qian; Lin Zhang; Charles R Brown; Erol Fikrig; Ruth R Montgomery
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

9.  Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).

Authors:  Pauline E Chugh; Blossom A Damania; Dirk P Dittmer
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

10.  The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity.

Authors:  Jonathan J Miner; Brian P Daniels; Bimmi Shrestha; Jose L Proenca-Modena; Erin D Lew; Helen M Lazear; Matthew J Gorman; Greg Lemke; Robyn S Klein; Michael S Diamond
Journal:  Nat Med       Date:  2015-11-02       Impact factor: 53.440

View more
  22 in total

1.  Immunosenescence: the importance of considering age in health and disease.

Authors:  B Weinberger
Journal:  Clin Exp Immunol       Date:  2017-01       Impact factor: 4.330

2.  Mapping innate and adaptive immune function in arbovirus infections.

Authors:  Daniel M Altmann
Journal:  Immunology       Date:  2018-05       Impact factor: 7.397

3.  Emerging viruses in older population Chikungunya, West Nile fever and Dengue.

Authors:  Lidvine Godaert; Moustapha Dramé; Claire Roubaud-Baudron
Journal:  Aging Clin Exp Res       Date:  2019-11-18       Impact factor: 3.636

4.  Aging hampers neutrophil extracellular traps (NETs) efficacy.

Authors:  Maurizio Sabbatini; Elisa Bona; Giorgia Novello; Mario Migliario; Filippo Renò
Journal:  Aging Clin Exp Res       Date:  2022-08-03       Impact factor: 4.481

5.  Virus infection of the CNS disrupts the immune-neural-synaptic axis via induction of pleiotropic gene regulation of host responses.

Authors:  Olga A Maximova; Daniel E Sturdevant; John C Kash; Kishore Kanakabandi; Yongli Xiao; Mahnaz Minai; Ian N Moore; Jeff Taubenberger; Craig Martens; Jeffrey I Cohen; Alexander G Pletnev
Journal:  Elife       Date:  2021-02-18       Impact factor: 8.140

6.  Both in vitro T cell proliferation and telomere length are decreased, but CD25 expression and IL-2 production are not affected in aged men.

Authors:  Froylan Albarrán-Tamayo; Blanca Murillo-Ortiz; Roberto González Amaro; Sergio López Briones
Journal:  Arch Med Sci       Date:  2019-09-04       Impact factor: 3.318

7.  Early onset senescence and cognitive impairment in a murine model of repeated mTBI.

Authors:  Nicole Schwab; YoungJun Ju; Lili-Naz Hazrati
Journal:  Acta Neuropathol Commun       Date:  2021-05-08       Impact factor: 7.801

8.  West Nile virus infection in suspected febrile typhoid cases in Xinjiang, China.

Authors:  Lei Cao; Shihong Fu; Zhi Lv; Chengjun Tang; Shiheng Cui; Xiaolong Li; Xiaoyan Gao; Minghua Li; Yuxi Cao; Wenwen Lei; Ying He; Huanyu Wang; Guodong Liang
Journal:  Emerg Microbes Infect       Date:  2017-06-07       Impact factor: 7.163

9.  Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected.

Authors:  Stephanie L Cumberworth; Jennifer A Barrie; Madeleine E Cunningham; Daniely Paulino Gomes de Figueiredo; Verena Schultz; Adrian J Wilder-Smith; Benjamin Brennan; Lindomar J Pena; Rafael Freitas de Oliveira França; Christopher Linington; Susan C Barnett; Hugh J Willison; Alain Kohl; Julia M Edgar
Journal:  Acta Neuropathol Commun       Date:  2017-06-23       Impact factor: 7.801

10.  The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection.

Authors:  Yi Yao; Dara M Strauss-Albee; Julian Q Zhou; Anna Malawista; Melissa N Garcia; Kristy O Murray; Catherine A Blish; Ruth R Montgomery
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.